Literature DB >> 189922

A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.

E T Creagan, R G Hahn, D L Ahmann, J H Edmonson, H F Bisel, R T Eagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 189922

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas.

Authors:  J H Edmonson; H J Long; R L Richardson; E T Creagan; S J Green
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Analysis of a series of sixty soft tissue sarcomas in adults treated with a cyclophosphamide-vincristine-adriamycin-dacarbazine (CYVADIC) combination.

Authors:  N B Bui; J Chauvergne; C Hocke; M Durand; R Brunet; J M Coindre
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.